CClinicalTrials.gg
CompletedNCT03534375Updated Oct 25, 2021

Gender Differences of Neuroanatomical and Neurophysiological Correlates of Risk-proneness in Early Adolescents

An observational study in Gender and Early Adolescent Behavior, sponsored by Texas Tech University. Completed at 1 site in United States. Open to participants aged 10 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-10-25.

Sponsored by Texas Tech University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
8
Ages
10 Years to 12 Years
Sex
All
01

Study summary

Risk-taking in early adolescence have has been found to be normative and even formative as it might fulfill the youth's needs to experiment different sensations, make independent decisions and learn from their consequences. Several theoretical models have suggested that male and female adolescents differ in risk-taking as a product of individual/contextual factors and neocortical functioning; however, the neurophysiological and neuropsychological correlates of those differences continue to be underexplored. Informed by Evolutionary Neuroandrogenic Theory, the investigators examine the links between gender, risk-proneness, gratification delay, self-control, self-efficacy, executive functions and neurophysiological-neuroanatomical correlates in early adolescents (age 10-12 years). Participants (N=24; 50% females) will complete behavioral measurements on study constructs and perform neuropsychological tests using fMRI scanning (e.g., Go/NoGo continuous performance, stop-signal reaction time, NIH Cognition Battery, delay discounting). Female and male groups will be compared on all outcome measures.

02

Conditions studied

  • Gender
  • Early Adolescent Behavior
03

In context

Lead sponsor

Texas Tech University is the lead sponsor of 82 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of healthy early adolescent (age 10-12 years) male and female subjects

Inclusion criteria

  • Early adolescents (age 10-12 years)
  • Male and female

Exclusion criteria

Exclusion Criteria:

  • Gross impairment of vision or hearing that would prevent the participants from performing neuropsychological tasks
  • Inability to read and follow written instructions
  • WISC-V IQ score of \< 80
  • Physical, neurological or concurrent psychiatric impairments that could affect cognitive and motor functions
  • Regular intake of medication that could alter visual, auditory, cognitive or motor functions
  • History of head injury that resulted in loss of consciousness / history of brain surgery
  • Current / past history of smoking and / or alcohol or drug abuse
  • Absolute contraindications to undergo MRI
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
8 participants (actual)
Patient registry
No

Groups and cohorts

  • Female Early Adolescents

    Other: The study is an observational cross sectional study

  • Male Early Adolescents

    Other: The study is an observational cross sectional study

Interventions

  • OtherThe study is an observational cross sectional study

    An intervention will not be performed

06

What researchers measure

Primary outcomes

  1. Female vs. Male differences of fMRI BOLD responses for SSRT Stop Signals

    Female vs. male differences of functional magnetic resonance imaging reactivity of the whole brain while performing a Stop Signal Reaction Time Task

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  2. Female vs. Male differences of fMRI BOLD responses in a Go-NoGo CPT

    Female vs. male differences of functional magnetic resonance imaging reactivity of the whole brain while performing a Go-NoGo Continuous Performance Task

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  3. Female vs. Male differences of brain structural connectivity

    Female vs. male differences of brain structural connectivity as measured by diffusion tensor imaging and analyzed using tract-based spatial statistics

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  4. Female vs. Male differences of brain structure

    Female vs. male differences of brain structure as determined by voxel based morphometry of structural magnetic resonance imaging data

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

Secondary outcomes

  1. Female vs. male differences in delay discounting

    Female vs. male differences in delay discounting as measures using a delay discounting task presented on a laptop computer

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  2. Female vs. male differences in stop signal delay

    Female vs. male differences in stop signal delay of a stop signal reaction time task performed in the magnetic resonance imaging scanner

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  3. Female vs. male differences in reaction times of correct Go responses

    Female vs. male differences in reaction times of correct Go responses performed in a Go-NoGo continuous performance task performed in the magnetic resonance imaging scanner

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  4. Female vs. male differences in commission errors in a Go-NoGo CPT

    Female vs. male differences commission errors in a Go-NoGo continuous performance task performed in the magnetic resonance imaging scanner

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  5. Female vs. male differences in Flanker Inhibitory Control and Attention Test

    Female vs. male differences in Flanker Inhibitory Control and Attention Test of the NIH Toolbox Cognition Battery

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  6. Female vs. male differences in Dimensional Change Card Sort Test

    Female vs. male differences in Dimensional Change Card Sort Test of the NIH Toolbox Cognition Battery

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  7. Female vs. male differences in Pattern Comparison Processing Speed Test

    Female vs. male differences in Pattern Comparison Processing Speed Test of the NIH Toolbox Cognition Battery

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  8. Female vs. male differences in risk-proneness

    Female vs. male differences in risk-proneness as measured by Impulsive Sensation Seeking Scale adapted by Raffaelli and Crocket (2003)

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  9. Female vs. male differences in sensation seeking

    Female vs. male differences in Brief Sensation Seeking Scale (BSSS) developed by Hoyle et al (2002)

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  10. Female vs. male differences in gratification delay

    Female vs. male differences in abbreviated 10 item Delayed Gratification Inventory (DGI-10) by Romer, Duckworth, Sznitman, \& Park (2010)

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  11. Female vs. male differences in self-control

    Female vs. male differences in Perrone, Sullivan, Pratt, \& Margaryan (2004) measure of self -control adapted from the Longitudinal Study of Adolescent and Adult Health (ADD Health)

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  12. Female vs. male differences in self-efficacy

    Female vs. male differences in General Self-Efficacy Scale (GSE) developed by Schwarzer \& Jerusalem (1995)

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

Other outcomes

  1. Female vs. male differences in commission errors in an SSRT

    Female vs. male differences in commission errors in a stop signal reaction time task performed in the magnetic resonance imaging scanner

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  2. Female vs. male differences in omission errors in an SSRT

    Female vs. male differences in omission errors in a stop signal reaction time task performed in the magnetic resonance imaging scanner

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  3. Female vs. male differences in omission errors in a Go-NoGo CPT

    Female vs. male differences omission errors in a Go-NoGo continuous performance task performed in the magnetic resonance imaging scanner

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  4. Female vs. male differences in Picture Sequence Memory Test

    Female vs. male differences in Picture Sequence Memory Test of the NIH Toolbox Cognition Battery

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  5. Female vs. male differences in List Sorting Working Memory Test

    Female vs. male differences in List Sorting Working Memory Test of the NIH Toolbox Cognition Battery

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

  6. Female vs. male differences in simple visual reaction time

    Female vs. male differences in a simple visual reaction time task programmed and presented in PsychoPy software environment on a laptop computer

    Time frame: Outcome will be measured on the first study visit (day 1) of each subject. This will also be the only time point of measurement. Outcomes of all recruited subjects within the specified study period will be considered when reporting the outcome measure.

07

Study locations

1 site
  • Texas Tech University - Department of Human Development and Family Studies
    Lubbock, Texas 79409, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03534375
Lead sponsor
Texas Tech University
Responsible party
Sponsor
First posted
May 23, 2018
Start date
May 14, 2018
Primary completion
Apr 30, 2019
Completion
Aug 31, 2019
Last update
Oct 25, 2021

Study contacts

Elizabeth Trejos-Castillo, PhD
principal investigator · Texas Tech University
Chanaka Kahathuduwa
study director · Texas Tech University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion